MENU
+Compare
IPSEY
Stock ticker: OTC
AS OF
Jan 8 closing price
Price
$36.80
Change
+$2.45 (+7.13%)
Capitalization
12.19B

IPSEY stock forecast, quote, news & analysis

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases... Show more

IPSEY
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for IPSEY with price predictions
Jan 09, 2026

IPSEY's RSI Indicator ascending out of oversold territory

The RSI Oscillator for IPSEY moved out of oversold territory on December 09, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In of the 25 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where IPSEY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 08, 2026. You may want to consider a long position or call options on IPSEY as a result. In of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IPSEY just turned positive on January 08, 2026. Looking at past instances where IPSEY's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

IPSEY moved above its 50-day moving average on January 08, 2026 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The 10-day moving average for IPSEY crossed bearishly below the 50-day moving average on December 19, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IPSEY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IPSEY broke above its upper Bollinger Band on January 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for IPSEY entered a downward trend on January 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.456) is normal, around the industry mean (38.595). P/E Ratio (23.476) is within average values for comparable stocks, (75.805). Projected Growth (PEG Ratio) (0.724) is also within normal values, averaging (2.020). IPSEY has a moderately low Dividend Yield (0.011) as compared to the industry average of (0.030). P/S Ratio (2.797) is also within normal values, averaging (51.857).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IPSEY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

IPSEY paid dividends on June 25, 2025

Ipsen S.A. IPSEY Stock Dividends
А dividend of $0.40 per share was paid with a record date of June 25, 2025, and an ex-dividend date of June 09, 2025. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teva Pharmaceutical Industries Limited (NYSE:TEVA), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), Avadel Pharmaceuticals plc (NASDAQ:AVDL), BioCryst Pharmaceuticals (NASDAQ:BCRX), Tilray Brands Inc. (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 22.12B. The market cap for tickers in the group ranges from 2.12K to 3.76T. TEVA holds the highest valuation in this group at 3.76T. The lowest valued company is CANQF at 2.12K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was 2%. For the same Industry, the average monthly price growth was 9%, and the average quarterly price growth was 21%. RGC experienced the highest price growth at 123%, while SXTC experienced the biggest fall at -91%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was 50%. For the same stocks of the Industry, the average monthly volume growth was 87% and the average quarterly volume growth was 138%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 65
Price Growth Rating: 54
SMR Rating: 80
Profit Risk Rating: 89
Seasonality Score: 22 (-100 ... +100)
View a ticker or compare two or three
IPSEY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
65 Quai Georges Gorse
Phone
+33 158335000
Employees
5072
Web
https://www.ipsen.com